The impact of α3β4 partial agonist AT-1001 on oxycodone withdrawal

Katherine M. Contreras, Alayna Palamar, Belle Buzzi, Aleny Oros, Burhan Buttar, Mariam Damaj, Nurulain T. Zaveri, D. Matthew Walentiny, M. Imad Damaj

Open source

DOI: 10.1016/j.drugalcdep.2026.113388
Published: 2026-11
Container: Drug and Alcohol Dependence
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.drugalcdep.2026.113388,
  title = {The impact of α3β4 partial agonist AT-1001 on oxycodone withdrawal},
  author = {Katherine M. Contreras and Alayna Palamar and Belle Buzzi and Aleny Oros and Burhan Buttar and Mariam Damaj and Nurulain T. Zaveri and D. Matthew Walentiny and M. Imad Damaj},
  year = {2026},
  journal = {Drug and Alcohol Dependence},
  doi = {10.1016/j.drugalcdep.2026.113388},
  url = {https://doi.org/10.1016/j.drugalcdep.2026.113388}
}

RIS

TY  - JOUR
TI  - The impact of α3β4 partial agonist AT-1001 on oxycodone withdrawal
AU  - Katherine M. Contreras
AU  - Alayna Palamar
AU  - Belle Buzzi
AU  - Aleny Oros
AU  - Burhan Buttar
AU  - Mariam Damaj
AU  - Nurulain T. Zaveri
AU  - D. Matthew Walentiny
AU  - M. Imad Damaj
PY  - 2026
JO  - Drug and Alcohol Dependence
DO  - 10.1016/j.drugalcdep.2026.113388
UR  - https://doi.org/10.1016/j.drugalcdep.2026.113388
ER  -

APA

Contreras, K. M., Palamar, A., Buzzi, B., Oros, A., Buttar, B., Damaj, M., Zaveri, N. T., Walentiny, D. M., & Damaj, M. I. (2026). The impact of α3β4 partial agonist AT-1001 on oxycodone withdrawal. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2026.113388

Source records

crossref · retrieved 2026-11-10T14:07:56.335Z